Los Angeles based private equity firm The Gores Group is acquiring a medical device firm, Therakos, from Ortho-Clinical Diagnostics, the company said this morning. Financial terms of the buy were not disclosed. Therakos is a New Jersey developer of extracorporeal photopheresis (ECP) immune modulation therapy products. The Gores Group said that Therakos develops systems used for treating T-Cell lymphomas and other immune-based diseases.
Top NewsMonday, October 15, 2012
Gores Group Buys Therakos